Survey on Awareness of Implantable Contact Lenses (Phakic Posterior Chamber Lenses) Among Men and Women in Their 20s-40s with Vision of 0.1 or Less
NQ Score
50/100
AI Summary (NQ-processed)
At Working Co., Ltd., the Japanese distributor of "IPCL®," an implantable contact lens approved by the Ministry of Health, Labour and Welfare in April 2025, conducted a survey on implantable contact lenses among men and women in their 20s to 40s nationwide. The survey found that over 70% of respondents were aware of the treatment, with nearly the same percentage expressing interest. The primary drivers of interest were the inconvenience and ongoing cost of glasses and traditional contact lenses, while the main deterrents were fear of surgery and safety concerns. Interest was notably higher among women in their 20s and 30s.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What company conducted the nationwide survey on implantable contact lenses?
- A: The survey was conducted by Working Co., Ltd., which sells the IPCL approved by the Ministry of Health, Labour and Welfare.
- Q: What material is used for the implantable contact lens known as IPCL?
- A: It uses an acrylic polymer material that is primarily composed of HEMA.
- Q: How does the implantable contact lens treatment differ from LASIK?
- A: Unlike LASIK, it does not shave the cornea, making it a highly reversible treatment where the lens can be removed in the future.
- Q: When did the implantable contact lens obtain regulatory approval and launch in Japan?
- A: It obtained regulatory approval from the Ministry of Health, Labour and Welfare in April 2025 and was launched in September of the same year.
- Q: What percentage of the survey subjects were aware of the treatment method of implantable contact lenses?
- A: According to the survey, more than seventy percent, specifically 72.8%, of the subjects were aware of the treatment method.